Response to FDA statement on termination of a primate nicotine research study

The US Food and Drug Administration (FDA)  announced yesterday that it terminated a study investigating the effects of nicotine in monkeys.  This announcement, which was accompanied by the release of many records and documents related to the animals’ care, is troubling for many reasons.  Among them, it again raises questions about oversight and decision-making. Nicotine … Continue reading Response to FDA statement on termination of a primate nicotine research study

Is the FDA undermining its own study and the experts it sent to review it?

The American Psychological Association has warned that the FDA may be winding down its own primate study, despite having started– but not completed, nor made public– an independent FDA review process. Why the FDA would stop the study before any report has been published will lead many into further questioning the influence that certain animal … Continue reading Is the FDA undermining its own study and the experts it sent to review it?

Speaking of Research Year in Review 2017

It’s been a great year for Speaking of Research. Visits to the website rose 30% to break new records in 2017, with more new content added than in any previous year. It is not just web traffic which saw a large rise, our media work also increased in 2017 as we provided comment to outlets … Continue reading Speaking of Research Year in Review 2017

Speaking of Research response to FDA announcement regarding nicotine research

For immediate release Speaking of Research response to FDA announcement regarding nicotine research Late on September 25, as reported by the Washington Post, the US Food and Drug Administration (FDA) made the startling announcement that it has suspended a nicotine research project involving non-human primates; the goal of this research is to build a better … Continue reading Speaking of Research response to FDA announcement regarding nicotine research